Literature DB >> 1677003

Five type I modules of fibronectin form a functional unit that binds to fibroblasts and Staphylococcus aureus.

J Sottile1, J Schwarzbauer, J Selegue, D F Mosher.   

Abstract

Fibronectin is a cell-adhesive protein comprised of three types of repeating homologous sequences, I, II, and III (Petersen, T.E., Thøgersen, H.C., Skorstengaard, K., Vibe-Pedersen, K., Sahl, P., Sottrup-Jensen, L., and Magnusson, S. (1983) Proc. Natl. Acad. Sci. U.S.A. 80, 137-141). The amino-terminal portion of fibronectin is comprised of five type I modules and mediates assembly of dimeric soluble fibronectin into insoluble fibrils by cultured fibroblasts, binding and cross-linking of fibronectin to Staphylococcus aureus, and binding and cross-linking of fibronectin to fibrin. It is not known whether these binding activities require individual type I modules, several modules, or all five modules. To answer this question, we generated recombinant truncated fibronectin molecules with deletions of or mutations in the amino-terminal type I modules. Binding to cellular fibronectin assembly sites and S. aureus required all five type I modules. In contrast, proteins with deletions of type I modules interacted well with fibrin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677003

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  The N-terminal 70-kDa fragment of fibronectin binds to cell surface fibronectin assembly sites in the absence of intact fibronectin.

Authors:  Bianca R Tomasini-Johansson; Douglas S Annis; Deane F Mosher
Journal:  Matrix Biol       Date:  2006-03-06       Impact factor: 11.583

2.  Fibrillin assembly requires fibronectin.

Authors:  Laetitia Sabatier; Daliang Chen; Christine Fagotto-Kaufmann; Dirk Hubmacher; Marc D McKee; Douglas S Annis; Deane F Mosher; Dieter P Reinhardt
Journal:  Mol Biol Cell       Date:  2008-11-26       Impact factor: 4.138

3.  N-terminal type I modules required for fibronectin binding to fibroblasts and to fibronectin's III1 module.

Authors:  J Sottile; D F Mosher
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

4.  Bivalent ligation of the collagen-binding modules of fibronectin by SFS, a non-anchored bacterial protein of Streptococcus equi.

Authors:  Wenjiang Ma; Hanqing Ma; Frances J Fogerty; Deane F Mosher
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

5.  Ail protein binds ninth type III fibronectin repeat (9FNIII) within central 120-kDa region of fibronectin to facilitate cell binding by Yersinia pestis.

Authors:  Tiffany M Tsang; Douglas S Annis; Malte Kronshage; Jesse T Fenno; Lisa D Usselman; Deane F Mosher; Eric S Krukonis
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

6.  Homocysteine modifies structural and functional properties of fibronectin and interferes with the fibronectin-fibrillin-1 interaction.

Authors:  Dirk Hubmacher; Laetitia Sabatier; Douglas S Annis; Deane F Mosher; Dieter P Reinhardt
Journal:  Biochemistry       Date:  2011-05-19       Impact factor: 3.162

Review 7.  Fibronectins, their fibrillogenesis, and in vivo functions.

Authors:  Jean E Schwarzbauer; Douglas W DeSimone
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

8.  Disruption of fibronectin matrix affects type IV collagen, fibrillin and laminin deposition into extracellular matrix of human trabecular meshwork (HTM) cells.

Authors:  Mark S Filla; Kaylee D Dimeo; Tiegang Tong; Donna M Peters
Journal:  Exp Eye Res       Date:  2017-08-30       Impact factor: 3.467

Review 9.  Cartilage destruction by matrix degradation products.

Authors:  Tadashi Yasuda
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

10.  iso-DGR sequences do not mediate binding of fibronectin N-terminal modules to adherent fibronectin-null fibroblasts.

Authors:  Jielin Xu; Lisa M Maurer; Brian R Hoffmann; Douglas S Annis; Deane F Mosher
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.